CGC Financial Services’s AbbVie ABBV Stock Holding History

CGC Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$195K	Sell	773 -75	-9%	-$16.1K	0.04%	70
2026 Q1	$184K	Sell	848 -199	-19%	-$44.1K	0.05%	64
2025 Q4	$239K	Sell	1,047 -11	-1%	-$2.51K	0.06%	56
2025 Q3	$245K	Hold	1,058	–	–	0.07%	54
2025 Q2	$196K	Hold	1,058	–	–	0.07%	62
2025 Q1	$222K	Sell	1,058 -73	-6%	-$14.2K	0.09%	50
2024 Q4	$201K	Hold	1,131	–	–	0.08%	53
2024 Q3	$223K	Buy	1,131 +209	+23%	+$39K	0.09%	49
2024 Q2	$158K	Hold	922	–	–	0.07%	53
2024 Q1	$168K	Buy	922 +68	+8%	+$11.7K	0.09%	51
2023 Q4	$132K	Buy	854 +225	+36%	+$32.8K	0.06%	69
2023 Q3	$93.7K	Hold	629	–	–	0.07%	64
2023 Q2	$84.7K	Buy	+629	New	+$92.2K	0.06%	71

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CGC Financial Services's ABBV Position: Q2 2026 in Review

CGC Financial Services reduced its AbbVie (ABBV) stake by 8.8% in Q2 2026, selling an estimated $16.1K and leaving 773 shares worth $195K. The position accounts for 0.04% of the portfolio, ranked #70.

CGC Financial Services first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. The position peaked at $245K in Q3 2025. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

CGC Financial Services held 773 shares of AbbVie worth $195K as of Q2 2026.
CGC Financial Services sold 75 AbbVie shares in Q2 2026, an estimated $16.1K.
AbbVie made up 0.04% of CGC Financial Services's portfolio in Q2 2026, its #70 holding.
CGC Financial Services first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
CGC Financial Services's AbbVie position peaked at $245K in Q3 2025.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CGC Financial Services's 13F filing for Q2 2026, filed 13 Jul 2026.